Skip to content

Insider · CIK 0002075458

Rebecca Ann Petersen

officer

Files at CV (CapsoVision, Inc). First filing -, latest -.

Rebecca Ann Petersen files SEC Form 4 as officer at CV (CapsoVision, Inc). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.

A track record needs three past buys with six months of prices behind them; Rebecca Ann Petersen has 0, so none is measured yet.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Transactions

Every row this insider has filed, 3 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Aug 18, 2025CV
CapsoVision, Inc
MOption exercise
Common Stock
+24,834$0.37$9,09724,834Aug 22, 2025
Aug 18, 2025CV
CapsoVision, Inc
MOption exercise
Stock Option (right to buy)derivative
-7,507$0.00$00Aug 22, 2025
Aug 18, 2025CV
CapsoVision, Inc
MOption exercise
Stock Option (right to buy)derivative
-17,327$0.00$03,694Aug 22, 2025

Questions about Rebecca Ann Petersen

Answered from the filings on this page, as of the latest one.

Is Rebecca Ann Petersen buying or selling?

Rebecca Ann Petersen has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.

How did Rebecca Ann Petersen's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Rebecca Ann Petersen has 0.

Where does Rebecca Ann Petersen file Form 4?

Rebecca Ann Petersen has filed Form 4 at CV (CapsoVision, Inc) as Director of Clinical Affairs. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.